- Health Distilled by Liverpool Lane
- Posts
- Health plan challengers, health systems and AI, aging endpoints in clinical trials and more!
Health plan challengers, health systems and AI, aging endpoints in clinical trials and more!
Healthcare through a Kentucky lens. It's niche. But neat!
Andrew Steen
September 15, 2026
Birds. On radar. That was a new one to me.
Health plans have to compete again
This is a really smart read from Julie Yoo at a16z. It’s particularly relevent given that the highest-ranking Fortune 500 company based in Kentucky is in the business of health plans.
Interesting.
Health systems and AI solutions
Report from the Center for Connected Medicine at UPMC and KLAS Research.
“Only 11 of 25 respondents say their organization has a data platform or other environment in which they can test and validate third-party AI solutions.”
FDA AI-Enabled Medical Device List
The FDA AI-Enabled Medical Device List is updated through the end of June 2026.
FDA has authorized 1,230 radiology devices, or 76% of all AI-enabled medical authorizations.
Louisville-based 3DR Labs, LLC’s AI Labs.
Proteomic clocks
“This work supports the goal of dual-purpose clinical trial designs that integrate aging endpoints into studies for specific disease indications.”
Pretty cool.
PBM channels
This is from Omada Health Inc.’s Investor Day 2026. PBM channels are an expected driver of growth.
I dig it.
Lastly, ICYMI
Forward to a friend and encourage them to subscribe.
Reply